Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

JTB Inhibitors

JTB, or Jumping Translocation Breakpoint, is a protein that has garnered interest in the field of genetics and cellular biology due to its unique role in cellular homeostasis and chromosomal stability. The protein is so named because of its involvement in translocations where parts of one chromosome jump to another, which can be a hallmark of various types of cancer. JTB is integral to the regulation of cellular growth and division, acting as a mediator in signaling pathways that control these processes. It is thought to interact with components of the cell's machinery that manage cellular stress and respond to growth signals, making it a critical player in maintaining the balance between cell survival and apoptosis, or programmed cell death. The proper functioning of JTB is crucial for ensuring that cells do not proliferate uncontrollably, a state which could lead to tumor development and progression.

Inhibiting JTB involves targeting this protein to disrupt its normal function, which can lead to the suppression of undesirable cellular proliferation and the potential restoration of normal cellular division and death processes. Mechanisms of inhibition can include small molecule inhibitors that bind directly to JTB, interfering with its ability to interact with other proteins or with DNA, thereby preventing it from carrying out its normal regulatory functions. Another method of inhibition might involve the use of antisense oligonucleotides or RNA interference strategies, which reduce the expression of the JTB gene, thus lowering the levels of the protein within the cell. These approaches aim to disrupt the pathways in which JTB is involved, particularly those related to the cell cycle and apoptosis. By inhibiting JTB, researchers aim to restore normal cellular control mechanisms that may be disrupted in diseases such as cancer. Moreover, exploring the inhibition of JTB could provide insights into the broader mechanisms of chromosomal stability and the cellular response to genetic stressors, contributing to a deeper understanding of cellular dynamics and disease pathology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Targets mTOR pathway by inhibiting mTORC1. This affects the Akt pathway, leading to a decrease in JTB phosphorylation and function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK1, consequently suppressing the ERK pathway. Alters JTB's interaction with caspases, affecting its role in apoptosis.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, dampening the PI3K/Akt/mTOR axis and reducing JTB phosphorylation, affecting its stability and function.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Targets MDM2-p53 interaction. Upregulates p53, affecting JTB's role in p53-dependent apoptosis.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Targets MEK1 and MEK2. Dampens the MAPK/ERK pathway, subsequently reducing JTB's interaction with JNK pathways in apoptosis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, thereby disrupting the PI3K/Akt pathway. Reduces JTB phosphorylation and its interaction with anti-apoptotic factors.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

NF-κB inhibitor, disrupts JTB's influence on pro-inflammatory genes, which can indirectly modulate apoptosis.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, affecting JTB’s ability to act as a scaffold protein in the JNK signaling pathway during apoptosis.

Obatoclax Mesylate

803712-79-0sc-364221
sc-364221A
5 mg
10 mg
$96.00
$141.00
(1)

Inhibits Bcl-2 family proteins. Reduces JTB's interaction with Bcl-2, affecting its anti-apoptotic function.

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$180.00
$610.00
4
(1)

Inhibits GSK3β, affecting Wnt signaling. Alters JTB's role in β-catenin regulation.